Sulfonylurea-No-More
Active member
Novo Nordisk is reportedly planning to decrease the list prices of Wegovy and Ozempic in the US by as much as 50% starting next year. (subscription required: https://www.wsj.com/health/pharma/n...wegovy-by-up-to-50-f1b038fb?mod=hp_lista_pos2)
The article mentions that both Ozempic and Wegovy could be listed for around $675 a month, starting Jan 1, 2027. This is supposedly half the current cost for Wegovy and about a 34% reduction for Ozempic. The price drops are supposed to apply to the pill forms too, like Rybelsus.
Apparently, this move is aimed at lowering out-of-pocket costs, particularly for those with high-deductible plans or coinsurance based on the list price.
It also mentions existing cash prices, which are already lower (in the range of $149 to $499 a month, depending on the specific drug and dosage) and that Lilly's Zepbound has cash prices from $299 to $449. The article refers to a government site, TrumpRx, for price comparisons.
Even if it's not a huge change for everyone, any price reduction is welcome. Hopefully, this is just the beginning.
The article mentions that both Ozempic and Wegovy could be listed for around $675 a month, starting Jan 1, 2027. This is supposedly half the current cost for Wegovy and about a 34% reduction for Ozempic. The price drops are supposed to apply to the pill forms too, like Rybelsus.
Apparently, this move is aimed at lowering out-of-pocket costs, particularly for those with high-deductible plans or coinsurance based on the list price.
It also mentions existing cash prices, which are already lower (in the range of $149 to $499 a month, depending on the specific drug and dosage) and that Lilly's Zepbound has cash prices from $299 to $449. The article refers to a government site, TrumpRx, for price comparisons.
Even if it's not a huge change for everyone, any price reduction is welcome. Hopefully, this is just the beginning.